Aqilion, a Swedish biopharma company developing therapies for diseases driven by chronic inflammation and dysregulated immune ...
The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback